Arcturus Therapeutics
ARCT
#6558
Rank
HK$4.13 B
Marketcap
HK$152.59
Share price
4.72%
Change (1 day)
1.98%
Change (1 year)

P/E ratio for Arcturus Therapeutics (ARCT)

P/E ratio as of November 2024 (TTM): 6.48

According to Arcturus Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 6.4769. At the end of 2022 the company had a P/E ratio of 49.9.

P/E ratio history for Arcturus Therapeutics from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202249.9-1143.2%
2021-4.78-61.42%
2020-12.4136.03%
2019-5.25150.39%
2018-2.10-8.84%
2017-2.30-2.49%
2016-2.36-66.18%
2015-6.98350.84%
2014-1.55-92.14%
2013-19.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
16.8 159.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.33-151.46% Bahamas

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.